Delisting risk
Artelo Biosciences
Develops cannabinoid and fatty-acid-binding-protein drug candidates for cancer supportive care and pain.
$0.7125
After-hours close+0.05 (+7.53%)
At close$0.6626(+0.24%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 1.31%Insiders —
Shares outstanding 3.49M · Float 2.17M · 62.4% free float
Insiders — no current Form 4 position.
A split settled inside the quarter being compared, so quarter-on-quarter change is not shown.
Institutions13F, as of Mar 31, 2026
10 holders · 45.6K shares
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Kathmere Capital Management, LLC | 13.3K | 0.38% | Apr 28, 2026 | |
| Jane Street Group, LLC | 13.1K | 0.38% | May 12, 2026 | |
| Vanguard Capital Management LLC | 10.1K | 0.29% | May 15, 2026 | |
| Vanguard Fiduciary Trust Co | 3.1K | 0.09% | May 8, 2026 | |
| Citigroup Inc | 3.1K | 0.09% | May 11, 2026 | |
| Tower Research Capital LLC (TRC) | 2.8K | 0.08% | May 15, 2026 | |
| Clear Street Group Inc. | 100 | 0.00% | May 15, 2026 | |
| Rothschild Investment LLC | 2 | 0.00% | May 7, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Armistice Capital, LLC | 9.99% | 235.8K | 13G | May 15, 2026 ↗ |
| Mitchell P. Kopin | 9.99% | 81.7K | 13G | Apr 3, 2026 ↗ |
InsidersForm 4
No current Form 4 position on record.
2 ten-percent owners hold 854 shares by Form 4, outside the officers-and-directors figure above · 8 people have not refiled in the last 18 months (583 shares), so they are not in the figure above
Latest trades
No open-market trades in the last 12 months.
CongressHouse and Senate disclosures
Not reported.